查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1922570

日本新生兒篩檢市場報告：依產品類型、技術、檢測類型和地區分類，2026-2034年

Japan Newborn Screening Market Report by Product, Technology, Test Type, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 118 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2025年，日本新生兒篩檢市場規模達6,820萬美元。展望未來，IMARC Group預測，該市場將從2026年到2034年以5.61%的複合年成長率成長，到2034年達到1.115億美元。醫療技術的不斷創新，以及為實現更準確的結果和更有效率的疾病檢測而做出的努力，是推動該地區市場成長的主要動力。

新生兒篩檢是指一系列檢查室評估和就地檢驗，旨在早期發現、診斷和干涉可能在出生後不會立即顯現的遺傳、代謝、血液和內分泌疾病。其主要目標是儘早識別可能導致嚴重發病率、死亡率和智慧障礙的疾病，以便在症狀出現前及時開始治療。典型的新生兒篩檢流程包括從嬰兒足跟採集少量血液樣本並進行簡單的血液檢測。此血液樣本用於評估多種疾病，包括代謝、內分泌和血液相關疾病，例如苯酮尿症 (PKU)、鐮狀囊腫纖維化和鐮狀細胞貧血。如果初步篩檢結果提示新生兒可能患有遺傳性疾病，則需要進一步的檢測以確診。這有助於及時啟動適當的治療，並制定後續護理計劃以維護嬰兒的健康。

日本新生兒篩檢市場趨勢：

日本新生兒篩檢市場正經歷顯著成長，主要驅動力來自父母對子女健康的日益關注，尤其是初為人父母者。這種關注的增加源自於嬰兒先天性疾病發生率的上升。父母越來越意識到早期發現和診斷對於及時進行醫療干預和治療至關重要，這進一步推動了市場擴張。醫療技術和基因檢測的進步顯著擴展了可篩檢疾病的範圍，進一步改善了市場前景。政府和醫療機構加速推進新生兒篩檢計畫也促進了市場的良性循環。持續的產品創新，例如次世代定序和串聯式質譜質譜技術的整合，提高了篩檢的準確性和速度，進一步推動了市場成長。消費者基因檢測的廣泛普及和對個人化醫療的日益重視，推動了根據個人特定基因譜量身定做的治療方案的出現，進一步刺激了市場需求。醫療保健成本上升、數位化快速發展、網際網路速度提高、線上健康社區的出現以及廣泛的研發活動等因素，將在預測期內促進市場的整體成長和發展。

本報告解答的關鍵問題

  • 日本新生兒篩檢市場至今發展狀況如何？未來幾年又將如何發展？
  • 新冠疫情對日本新生兒篩檢市場產生了哪些影響？
  • 日本新生兒篩檢市場依產品分類的組成是怎樣的？
  • 日本新生兒篩檢市場按技術分類的情況如何？
  • 日本新生兒篩檢市場依檢測類型分類的組成是怎樣的？
  • 日本新生兒篩檢市場價值鏈的不同階段有哪些？
  • 日本新生兒篩檢的主要促進因素和挑戰是什麼？
  • 日本新生兒篩檢市場的結構是怎麼樣的？主要參與者有哪些？
  • 日本新生兒篩檢市場競爭有多激烈？

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
  • 市場估值
  • 調查方法

第3章執行摘要

第4章 日本新生兒篩檢市場—簡介

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭資訊

第5章 日本新生兒篩檢市場概覽

  • 過去和當前的市場趨勢（2020-2025）
  • 市場預測（2026-2034）

第6章 日本新生兒篩檢市場－依產品細分

  • 裝置
  • 試劑

第7章 日本新生兒篩檢市場－依技術細分

  • 串聯式質譜質譜法
  • 脈搏血氧計
  • 基於酵素的檢測
  • DNA檢測
  • 電泳
  • 其他

第8章：日本新生兒篩檢市場－依檢測類型細分

  • 乾血斑測試
  • CCHD
  • 聽力篩檢

第9章：日本新生兒篩檢市場：按地區分類

  • 關東地區
  • 關西、近畿地區
  • 中部地區
  • 九州和沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第10章：日本新生兒篩檢市場：競爭格局

  • 概述
  • 市場結構
  • 市場公司定位
  • 關鍵成功策略
  • 競爭對手儀錶板
  • 企業估值象限

第11章主要企業概況

第12章：日本新生兒篩檢市場：產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第13章附錄

簡介目錄
Product Code: SR112026A19397

Japan newborn screening market size reached USD 68.2 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 111.5 Million by 2034, exhibiting a growth rate (CAGR) of 5.61% during 2026-2034 . Continuous innovations in medical technology for more accurate outcomes and efficiency of disease detection are primarily driving the regional market.

Access the full market insights report Request Sample

Newborn screening encompasses a series of laboratory assessments and point-of-care examinations designed for the early detection, diagnosis, and intervention of genetic, metabolic, hematological, or hormonal disorders that may not manifest immediately after birth. The primary objective is to identify diseases that have the potential to cause significant morbidity, mortality, and intellectual disability (ID) at an early stage, enabling prompt initiation of treatment before symptoms become evident. The typical newborn screening process involves the collection of a small blood sample from the baby's heel, which is subjected to a straightforward blood test. Subsequently, the blood sample undergoes testing to assess various conditions, including metabolic disorders, endocrine irregularities, and blood-related ailments such as phenylketonuria (PKU), cystic fibrosis, and sickle cell anemia. Should the initial screening results suggest a genetic disorder in the newborn, additional confirmatory testing becomes necessary to validate the diagnosis. This enables timely administration of appropriate treatment and the establishment of a follow-up care plan for the infant's well-being.

JAPAN NEWBORN SCREENING MARKET TRENDS :

The Japan newborn screening market is witnessing significant growth, primarily driven by heightened parental concerns for their children's health, especially among new parents. This concern is rooted in the increasing prevalence of congenital conditions in infants. Parents are becoming more aware of the critical role early detection and diagnosis play in facilitating timely medical intervention and treatment, further propelling the market's expansion. Advancements in medical technology and genetic testing have significantly broadened the range of disorders that can be screened for, enhancing the market's prospects. Governments and healthcare organizations are increasingly adopting newborn screening programs, adding to the market's positive trajectory. Ongoing product innovations, such as the integration of next-generation sequencing and tandem mass spectrometry, offer improved screening accuracy and speed, further bolstering market growth. The availability of direct-to-consumer genetic testing and a growing focus on personalized medicine are driving tailored treatments tailored to individuals' specific genetic profiles, further stimulating market demand. Factors such as increased healthcare expenditure, rapid digitization, higher internet speeds, the emergence of online health communities, and extensive research and development (R&D) efforts will contribute to the market's overall growth and advancement over the forecasted period.

JAPAN NEWBORN SCREENING MARKET SEGMENTATION:

Product Insights:

  • To get detailed segment analysis of this market Request Sample
  • Instruments
  • Reagents

Technology Insights:

  • Tandem Mass Spectrometry
  • Pulse Oximetry
  • Enzyme Based Assay
  • DNA Assay
  • Electrophoresis
  • Others

Test Type Insights:

  • Dry Blood Spot Test
  • CCHD
  • Hearing Screen

Regional Insights:

  • To get detailed regional analysis of this market Request Sample
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan newborn screening market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan newborn screening market?
  • What is the breakup of the Japan newborn screening market on the basis of product?
  • What is the breakup of the Japan newborn screening market on the basis of technology?
  • What is the breakup of the Japan newborn screening market on the basis of test type?
  • What are the various stages in the value chain of the Japan newborn screening market?
  • What are the key driving factors and challenges in the Japan newborn screening?
  • What is the structure of the Japan newborn screening market and who are the key players?
  • What is the degree of competition in the Japan newborn screening market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Newborn Screening Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Newborn Screening Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Newborn Screening Market - Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Reagents
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)

7 Japan Newborn Screening Market - Breakup by Technology

  • 7.1 Tandem Mass Spectrometry
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Pulse Oximetry
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Enzyme Based Assay
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 DNA Assay
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Electrophoresis
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Others
    • 7.6.1 Historical and Current Market Trends (2020-2025)
    • 7.6.2 Market Forecast (2026-2034)

8 Japan Newborn Screening Market - Breakup by Test Type

  • 8.1 Dry Blood Spot Test
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 CCHD
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Hearing Screen
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)

9 Japan Newborn Screening Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Product
    • 9.1.4 Market Breakup by Technology
    • 9.1.5 Market Breakup by Test Type
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Product
    • 9.2.4 Market Breakup by Technology
    • 9.2.5 Market Breakup by Test Type
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Product
    • 9.3.4 Market Breakup by Technology
    • 9.3.5 Market Breakup by Test Type
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Product
    • 9.4.4 Market Breakup by Technology
    • 9.4.5 Market Breakup by Test Type
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Product
    • 9.5.4 Market Breakup by Technology
    • 9.5.5 Market Breakup by Test Type
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Product
    • 9.6.4 Market Breakup by Technology
    • 9.6.5 Market Breakup by Test Type
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Product
    • 9.7.4 Market Breakup by Technology
    • 9.7.5 Market Breakup by Test Type
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Product
    • 9.8.4 Market Breakup by Technology
    • 9.8.5 Market Breakup by Test Type
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Newborn Screening Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Newborn Screening Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix